Friedmann, PhD, MD, Nadav, United States

• Journal of Opioid Management Vol. 7 No. 3 (2011): May/June - Articles
  Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic pain
  Abstract
• Journal of Opioid Management Vol. 14 No. 6 (2018): November/December - Clinical Report
  A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation
  Abstract
• Journal of Opioid Management Vol. 11 No. 2 (2015): March/April - Articles
  The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment
  Abstract
• Journal of Opioid Management Vol. 14 No. 6 (2018): November/December - Articles
  Abuse-deterrent properties of REMOXY® ER, a high-viscosity extended-release oxycodone formulation
  Abstract